Freedom of Information

Title
Prescribing cancer
Reference Number
RF24-061
Request Details
  1. in the past 6 months, how many patients were treated with a combination of both Encorafenib (Braftovi) + Binimetnib (Mektovi) for the following diseases:

a. Metastatic Melanoma
b. Colorectal Cancer
c. Any other indications

  1. In the past 6 months, how many patients were treated with a combination of Dabrafenib + Trametinib for the following diseases:

a. Metastatic Melanoma
b. Adjuvant Melanoma
c. BRAF mutated Lung Cancer

Response
  • rf24-061-response.pdf
    • Date of Disclosure
    01/03/2024